Growth Metrics

C4 Therapeutics (CCCC) EBT Margin (2019 - 2026)

C4 Therapeutics' quarterly EBT Margin came in at 408.47% in Q1 2026, down 4480.0% year-on-year from 9.33% in Q1 2025, and down 120.95% quarter-over-quarter from 184.87% in Q4 2025.

C4 Therapeutics has reported EBT Margin for 8 years, with the latest figure at 408.47% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 4480.0% year-over-year to 408.47%; the trailing twelve-month figure through Mar 2026 stood at 297.41% (down 3814.0% YoY), and the FY2025 full-year result was 291.74%, up 385.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 408.47%, down from 184.87% in the prior quarter.
  • The five-year high for EBT Margin was 147.56% in Q2 2024, with the low at 1348.42% in Q2 2023.
  • Average EBT Margin over 5 years is 558.95%, with a median of 408.47% recorded in 2026.
  • Year-over-year, EBT Margin plunged 122492 bps in 2022 and jumped 120086 bps in 2024.
  • Tracing CCCC's EBT Margin over 5 years: stood at 1302.91% in 2022, then advanced by 19 bps to 1057.25% in 2023, then surged by 37 bps to 665.29% in 2024, then jumped by 72 bps to 184.87% in 2025, then sank by 121 bps to 408.47% in 2026.
  • The last three EBT Margin figures came in at 408.47% (Q1 2026), 184.87% (Q4 2025), and 286.43% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 41.95%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 18.99%
10 C4 Therapeutics 561.03 Mn 325.36 Mn - -408.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -408.47%
Dec 31, 2025 -184.87%
Sep 30, 2025 -286.43%
Jun 30, 2025 -402.60%
Mar 31, 2025 -363.66%
Dec 31, 2024 -665.29%
Sep 30, 2024 -160.57%
Jun 30, 2024 -147.56%
Mar 31, 2024 -933.23%
Dec 31, 2023 -1,057.25%
Sep 30, 2023 -235.13%
Jun 30, 2023 -1,348.42%
Mar 31, 2023 -925.25%
Dec 31, 2022 -1,302.91%
Sep 30, 2022 -473.17%
Jun 30, 2022 -194.29%
Mar 31, 2022 -413.12%
Dec 31, 2021 -77.99%
Sep 30, 2021 -290.39%
Jun 30, 2021 -230.86%
Mar 31, 2021 -282.40%
Dec 31, 2020 -265.30%
Sep 30, 2020 -260.47%
Jun 30, 2020 -113.35%
Mar 31, 2020 -177.22%
Dec 31, 2019 -123.27%
Sep 30, 2019 -176.06%